﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.1" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-09-17T12:41:21-07:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>203564302</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Dufault CPA Ltd</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
        <CityNm>Waseca</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>56093</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>263070514</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Rosenau Family Research Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>ROSE</BusinessNameControlTxt>
      <PhoneNum>5078338144</PhoneNum>
      <USAddress>
        <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
        <CityNm>Waseca</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>56093</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Paul Rosenau</PersonNm>
      <PersonTitleTxt>President</PersonTitleTxt>
      <SignatureDt>2024-09-07</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Jared J Dufault</PreparerPersonNm>
      <PTIN>P00307631</PTIN>
      <PhoneNum>5078338144</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-08-08 14:25:15Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="11">
    <IRS990PF documentId="IRS990PF" referenceDocumentId="GeneralExplanation" softwareId="23017517" softwareVersionNum="2023v5.1">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>32096088</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>11000</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>1836</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>1836</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>848561</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>848561</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>1331521</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>13158607</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>1331521</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="OtherIncomeSchedule2">123878</OtherIncomeRevAndExpnssAmt>
        <TotalRevAndExpnssAmt>2316796</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>2181918</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>302500</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>31875</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>270625</CompOfcrDirTrstDsbrsChrtblAmt>
        <PensionEmplBnftRevAndExpnssAmt>88408</PensionEmplBnftRevAndExpnssAmt>
        <PensionEmplBnftNetInvstIncmAmt>9882</PensionEmplBnftNetInvstIncmAmt>
        <PensionEmplBnftDsbrsChrtblAmt>78526</PensionEmplBnftDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="LegalFeesSchedule">261260</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>261260</LegalFeesNetInvstIncmAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="AccountingFeesSchedule">13280</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>13280</AccountingFeesNetInvstIncmAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="OtherProfessionalFeesSchedule">129157</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>129157</OtherProfFeesNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="TaxesSchedule">32179</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>7179</TaxesNetInvstIncmAmt>
        <TravConfMeetingRevAndExpnssAmt>10528</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingDsbrsChrtblAmt>10528</TravConfMeetingDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="OtherExpensesSchedule AmortizationSchedule">389250</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>242704</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>125037</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>1226562</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>695337</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>484716</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>1266475</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>1266475</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>2493037</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>695337</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>1751191</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-176241</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>1486581</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>484</CashBOYAmt>
        <CashEOYAmt>484</CashEOYAmt>
        <CashEOYFMVAmt>484</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>891541</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>215910</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>215910</SavAndTempCashInvstEOYFMVAmt>
        <PrepaidExpensesEOYAmt>7523</PrepaidExpensesEOYAmt>
        <PrepaidExpensesEOYFMVAmt>7523</PrepaidExpensesEOYFMVAmt>
        <CorporateStockBOYAmt>27325230</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="InvestmentsCorpStockSchedule">27811734</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>29737735</CorporateStockEOYFMVAmt>
        <OtherInvestmentsBOYAmt>2255922</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="InvestmentsOtherSchedule2">2255922</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>2134436</OtherInvestmentsEOYFMVAmt>
        <TotalAssetsBOYAmt>30473177</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>30291573</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>32096088</TotalAssetsEOYFMVAmt>
        <AccountsPayableBOYAmt>6122</AccountsPayableBOYAmt>
        <AccountsPayableEOYAmt>759</AccountsPayableEOYAmt>
        <GrantsPayableBOYAmt>1347728</GrantsPayableBOYAmt>
        <GrantsPayableEOYAmt>1339690</GrantsPayableEOYAmt>
        <TotalLiabilitiesBOYAmt>1353850</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>1340449</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <CapitalStockBOYAmt>28138467</CapitalStockBOYAmt>
        <CapitalStockEOYAmt>28138467</CapitalStockEOYAmt>
        <RetainedEarningBOYAmt>980860</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>812657</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>29119327</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>28951124</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>30473177</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>30291573</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>29119327</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-176241</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt referenceDocumentId="OtherIncreasesSchedule">8038</OtherIncreasesAmt>
        <SubtotalAmt>28951124</SubtotalAmt>
        <TotNetAstOrFundBalancesEOYAmt>28951124</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>4,171.011 Dimensional Fund Advisors Two-Year Glob</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-11-29</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>39874</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>40010</CostOrOtherBasisAmt>
          <GainOrLossAmt>-136</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-136</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,538.071 Dimensional Fund Advisors Five-Year Glob</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-01-05</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>25127</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25010</CostOrOtherBasisAmt>
          <GainOrLossAmt>117</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>117</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>8,568.548 Vanguard Short Term Treasury Admiral</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-11-29</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>85084</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>85020</CostOrOtherBasisAmt>
          <GainOrLossAmt>64</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>64</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>50,886.437 Dimensional Fund Advisors Two-Year Glob</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-09-11</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>486465</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>509378</CostOrOtherBasisAmt>
          <GainOrLossAmt>-22913</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-22913</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,691.376 Dimensional Fund Advisors Intl Sm Cap</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-01-27</SoldDt>
          <GrossSalesPriceAmt>54921</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>58456</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3535</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3535</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,165.443 Dimensional Fund Advisors US Sm Cap</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>92043</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>87226</CostOrOtherBasisAmt>
          <GainOrLossAmt>4817</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4817</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>170,307.630 Dimensional Fund Advisors Five-Year Glob</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>1686036</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1843742</CostOrOtherBasisAmt>
          <GainOrLossAmt>-157706</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-157706</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,022.622 Stone Ridge Trust II Reinsurance</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-02-24</SoldDt>
          <GrossSalesPriceAmt>43728</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>41258</CostOrOtherBasisAmt>
          <GainOrLossAmt>2470</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2470</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>133,830.873 Vanguard Short Term Treasury Admiral</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-02-09</SoldDt>
          <GrossSalesPriceAmt>1328922</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1410527</CostOrOtherBasisAmt>
          <GainOrLossAmt>-81605</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-81605</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>7,941.653 DFA US High Relative Profitability</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-09-27</SoldDt>
          <GrossSalesPriceAmt>146990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>145393</CostOrOtherBasisAmt>
          <GainOrLossAmt>1597</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1597</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>4214.087 DFA US High Relative Profitability</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2023-11-21</SoldDt>
          <GrossSalesPriceAmt>81954</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>74382</CostOrOtherBasisAmt>
          <GainOrLossAmt>7572</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7572</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>49,382.716 DFA US High Relative Profitability</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>999990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>600197</CostOrOtherBasisAmt>
          <GainOrLossAmt>399793</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>399793</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>3,319.502 DFA International High Relative</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-11-21</SoldDt>
          <GrossSalesPriceAmt>39990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>43109</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3119</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3119</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>67,080.507 DFA International High Relative</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>832459</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>650053</CostOrOtherBasisAmt>
          <GainOrLossAmt>182406</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>182406</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>68,677.259 DFA Global Real Estate Securities</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>690197</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>650910</CostOrOtherBasisAmt>
          <GainOrLossAmt>39287</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>39287</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>6,650.943 DFA Emerging Markets Core Equity</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-09-27</SoldDt>
          <GrossSalesPriceAmt>140990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>169009</CostOrOtherBasisAmt>
          <GainOrLossAmt>-28019</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-28019</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,920.889 DFA Emerging Markets Core Equity</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-11-21</SoldDt>
          <GrossSalesPriceAmt>41923</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>48748</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6825</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6825</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>52,355.168 DFA US Micro-Cap Portfolio</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>1350753</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1047748</CostOrOtherBasisAmt>
          <GainOrLossAmt>303005</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>303005</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>26,921.749 DFA International Small-Cap Value</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>555924</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>509511</CostOrOtherBasisAmt>
          <GainOrLossAmt>46413</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>46413</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>7,584.951 DFA International Value III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-09-27</SoldDt>
          <GrossSalesPriceAmt>124990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>139093</CostOrOtherBasisAmt>
          <GainOrLossAmt>-14103</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-14103</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>67,016.317 DFA International Value III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-26</SoldDt>
          <GrossSalesPriceAmt>1149990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1056716</CostOrOtherBasisAmt>
          <GainOrLossAmt>93274</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>93274</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>22,064.057 DFA US Large-Cap Value III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>619990</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>595338</CostOrOtherBasisAmt>
          <GainOrLossAmt>24652</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>24652</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>995.000 Vanguard Intl Fd FTSE Developed</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2023-11-21</SoldDt>
          <GrossSalesPriceAmt>45292</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>49058</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3766</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3766</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>5,830.000 Vanguard Intl Fd FTSE Developed</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>272871</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>258989</CostOrOtherBasisAmt>
          <GainOrLossAmt>13882</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>13882</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>12,135.000 Vanguard Index FDS Vanguard Value ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-20</SoldDt>
          <GrossSalesPriceAmt>1799124</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1381719</CostOrOtherBasisAmt>
          <GainOrLossAmt>417405</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>417405</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>586.000 Vanguard Index FDS Vanguard Total</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-04-27</AcquiredDt>
          <SoldDt>2023-09-27</SoldDt>
          <GrossSalesPriceAmt>123469</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>123063</CostOrOtherBasisAmt>
          <GainOrLossAmt>406</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>406</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>889.000 Vanguard Index FDS Vanguard Total</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-11-21</SoldDt>
          <GrossSalesPriceAmt>199303</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>183423</CostOrOtherBasisAmt>
          <GainOrLossAmt>15880</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>15880</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>DFA US Micro-Cap Portfolio</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-14</SoldDt>
          <GrossSalesPriceAmt>19835</GrossSalesPriceAmt>
          <GainOrLossAmt>19835</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>19835</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>DFA International Small-Cap Value</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-12</SoldDt>
          <GrossSalesPriceAmt>690</GrossSalesPriceAmt>
          <GainOrLossAmt>690</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>690</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>DFA US Small-Cap Value Portfolio</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-14</SoldDt>
          <GrossSalesPriceAmt>15809</GrossSalesPriceAmt>
          <GainOrLossAmt>15809</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>15809</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>DFA US Large-Cap Value III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2000-01-01</AcquiredDt>
          <SoldDt>2023-12-14</SoldDt>
          <GrossSalesPriceAmt>63874</GrossSalesPriceAmt>
          <GainOrLossAmt>63874</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>63874</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>1331521</CapitalGainNetIncomeAmt>
        <NetShortTermCapitalGainLossAmt>45</NetShortTermCapitalGainLossAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>20663</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>20663</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>20663</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>37731</EstimatedPlusOvpmtIncmTxAmt>
        <TotalPaymentsAndCreditsAmt>37731</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="IRS2220">X</Form2220AttachedInd>
        <OverpaymentAmt>17068</OverpaymentAmt>
        <AppliedToESTaxAmt>17068</AppliedToESTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>MN</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>www.rosenaufoundation.org</WebsiteAddressTxt>
        <PersonsWithBooksName>
          <BusinessNameLine1Txt>Dufault CPA Ltd</BusinessNameLine1Txt>
        </PersonsWithBooksName>
        <PhoneNum>5078338144</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
          <CityNm>Waseca</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>56093</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <ActsFailToQlfyAsExceptionsInd>false</ActsFailToQlfyAsExceptionsInd>
        <UncorrectedPriorActsInd>false</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Paul Rosenau</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>President</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>5.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Gillian Hauboldt</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Treasurer</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Mariah Stone Mary Kay Delvo</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Secretary</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Heather Techmeier</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>127500</CompensationAmt>
          <EmployeeBenefitProgramAmt>29772</EmployeeBenefitProgramAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Dr Gabriel Cohn</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>175000</CompensationAmt>
          <EmployeeBenefitProgramAmt>36412</EmployeeBenefitProgramAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Julie McCarrier</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Li Ou</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Phil Christianson</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Marci Sontag</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Karlita Blackwell</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>28975488</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>432452</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>2090684</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>31498624</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>31498624</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>472479</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>31026145</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>1551307</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>1551307</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>20663</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>20663</TotalTaxAmt>
        <DistributableBeforeAdjAmt>1530644</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>123878</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>1654522</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>1654522</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>1751191</ExpensesAndContributionsAmt>
        <QualifyingDistributionsAmt>1751191</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>1654522</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>352443</UndistributedIncomePYAmt>
        <QualifyingDistributionsAmt>1751191</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>352443</AppliedToYear1Amt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>1398748</AppliedToCurrentYearAmt>
        <UndistributedIncomeCYAmt>255774</UndistributedIncomeCYAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>Paul Rosenau</ContributingManagerNm>
        <ApplicationSubmissionInfoGrp>
          <RecipientPersonNm>Paul Rosenau</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </RecipientUSAddress>
          <RecipientPhoneNum>5078338144</RecipientPhoneNum>
          <RecipientEmailAddressTxt>info@dufaultcpa.com</RecipientEmailAddressTxt>
          <FormAndInfoAndMaterialsTxt>Letter Outlining Project - Including Financial Data</FormAndInfoAndMaterialsTxt>
          <SubmissionDeadlinesTxt>None</SubmissionDeadlinesTxt>
          <RestrictionsOnAwardsTxt>Childhood Diseases and Newborn Screening for Disease - Particularly Krabbe's and Cystic Fibrosis</RestrictionsOnAwardsTxt>
        </ApplicationSubmissionInfoGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function</GrantOrContributionPurposeTxt>
          <Amt>85000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Biomedical Research Institute of NJ</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>140 East Hanover Avenue</AddressLine1Txt>
            <CityNm>Cedar Knools</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07927</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Psychosine Profiling and Evaluation as a Therapeutic for KD</GrantOrContributionPurposeTxt>
          <Amt>129834</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Buffalo</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>520 Lee Entrance Suite 211</AddressLine1Txt>
            <CityNm>Amherst</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>14228</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Innovative Model Systems to Study &amp; Boost Innate Immunity in KD</GrantOrContributionPurposeTxt>
          <Amt>205983</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Connecticut Health Ce</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>263 Farmington Avenue</AddressLine1Txt>
            <CityNm>Farmington</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Evaluation of Immunomodulatory Therapy for the Treatment of KD</GrantOrContributionPurposeTxt>
          <Amt>17950</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>KrabbeConnect</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>PO Box 264</AddressLine1Txt>
            <CityNm>Rosemount</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55068</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Parent-Reported Disease Burden in Infantile &amp; Late Infantile KD</GrantOrContributionPurposeTxt>
          <Amt>122708</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Children's Hospital of Chicago</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>225 E Chicago Avenue</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60611</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Caregiver and Clinician Awareness for Early CF</GrantOrContributionPurposeTxt>
          <Amt>400000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Pennsylvania</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3451 Walnut Street 5th Floor</AddressLine1Txt>
            <CityNm>Philadelphia</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19104</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Elucidating the Mechanisms Underlying Macrophage Dysfunction in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Dysfunction of Brain Synapsis in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Effects of Motor Learning on Efficacy and Safety of AAV-Gene Therapy in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>1266475</TotalGrantOrContriPdDurYrAmt>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>Biomedical Research Institute of NJ</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>140 East Hanover Avenue</AddressLine1Txt>
            <CityNm>Cedar Knools</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07927</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Psychosine Profiling and Evaluation as a Therapeutic for KD</GrantOrContributionPurposeTxt>
          <Amt>149154</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>Duke University</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>40 Duke Medicine Circle 124 Davison</AddressLine1Txt>
            <CityNm>Durham</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27710</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Improving KD Family Experience Through Communication and Promoting</GrantOrContributionPurposeTxt>
          <Amt>375000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Cennecticut Health Ce</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>263 Farmington Avenue</AddressLine1Txt>
            <CityNm>Farmington</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Evaluation of Immunomodulatory Therapy for the Treatment of KD</GrantOrContributionPurposeTxt>
          <Amt>63342</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Pennsylvania</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3451 Walnut Street 5th Floor</AddressLine1Txt>
            <CityNm>Philadelphia</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19104</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Elucidating the Mechanisms Underlying Macrophage Dysfunction in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>KrabbeConnect</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>PO Box 264</AddressLine1Txt>
            <CityNm>Rosemount</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55068</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Parent-Reported Disease Burden in Infantile &amp; Late Infantile KD</GrantOrContributionPurposeTxt>
          <Amt>123982</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function</GrantOrContributionPurposeTxt>
          <Amt>170000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Effects of Motor Learning on Efficacy and Safety of AAV-Gene Therapy in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Dysfunction of Brain Synapsis in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Kansas</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>2060 W 39th Ave</AddressLine1Txt>
            <CityNm>Kansas City</CityNm>
            <StateAbbreviationCd>KS</StateAbbreviationCd>
            <ZIPCd>66103</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Improving Developmental Outcomes in Mouse Models of KD</GrantOrContributionPurposeTxt>
          <Amt>28212</Amt>
        </GrantOrContriApprvForFutGrp>
        <TotalGrantOrContriApprvFutAmt>1339690</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>1836</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>848561</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>1331521</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>Returned Grants</Desc>
          <ExclusionCd>1</ExclusionCd>
          <ExclusionAmt>123878</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>2305796</ExclusionAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>2305796</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="23017517" softwareVersionNum="2023v5.1">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>M6P Therapeutics</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>20 S Sarah Street</AddressLine1Txt>
          <CityNm>St Louis</CityNm>
          <StateAbbreviationCd>MO</StateAbbreviationCd>
          <ZIPCd>63108</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>5000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>Forge Biologics Inc</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>3900 Gantz Rd</AddressLine1Txt>
          <CityNm>Grove City</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>43123</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>5000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <AccountingFeesSchedule documentId="AccountingFeesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <AccountingFeesDetail>
        <CategoryTxt>Dufault CPA Ltd</CategoryTxt>
        <Amt>13280</Amt>
        <NetInvestmentIncomeAmt>13280</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <InvestmentsCorpStockSchedule documentId="InvestmentsCorpStockSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <InvestmentsCorporateStockGrp>
        <StockNm>170,307.630 shs Five Year Global Fix</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>40,052.111 shs US Large Cap Value III</StockNm>
        <EOYBookValueAmt>852464</EOYBookValueAmt>
        <EOYFMVAmt>1145490</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>68,677.259 shs Global Real Estate</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>16,505.927 shs US Small Cap Value Port</StockNm>
        <EOYBookValueAmt>540573</EOYBookValueAmt>
        <EOYFMVAmt>741776</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>16,741.000 shs Short-Term Treasury</StockNm>
        <EOYBookValueAmt>969136</EOYBookValueAmt>
        <EOYFMVAmt>976503</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>52,355.168 shs US Micro Cap</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>15,741.072 shs Intl Value III Port</StockNm>
        <EOYBookValueAmt>155530</EOYBookValueAmt>
        <EOYFMVAmt>271219</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>1,022.622 shs Reinsurance Risk Prem</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>29,613.125 shs Intl Small Cap Value</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>52,361.584 shs US High Relative Prof</StockNm>
        <EOYBookValueAmt>571270</EOYBookValueAmt>
        <EOYFMVAmt>1077078</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>85,151.631 shs Emerging Mkts Core</StockNm>
        <EOYBookValueAmt>1750584</EOYBookValueAmt>
        <EOYFMVAmt>1908248</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>70,400.009 shs Intl Hgh Relative</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>262,830.793 shs Baird Core Plus Bond Fd</StockNm>
        <EOYBookValueAmt>3046006</EOYBookValueAmt>
        <EOYFMVAmt>2672989</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>101,258.844 shs Two Year Global Fixed</StockNm>
        <EOYBookValueAmt>1007901</EOYBookValueAmt>
        <EOYFMVAmt>979173</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>206,096.190 shs Intmd Term Invmt Grade</StockNm>
        <EOYBookValueAmt>2059702</EOYBookValueAmt>
        <EOYFMVAmt>1788915</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>20,363.000 shs Intl Fd FTSE Dev Mkt ETF</StockNm>
        <EOYBookValueAmt>702551</EOYBookValueAmt>
        <EOYFMVAmt>975388</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>3,789.000 shs Small-Cap Value ETF</StockNm>
        <EOYBookValueAmt>492308</EOYBookValueAmt>
        <EOYFMVAmt>681906</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>12,135.000 shs Value ETF</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>21,761.000 shs Total Stk Mkt ETF</StockNm>
        <EOYBookValueAmt>4017931</EOYBookValueAmt>
        <EOYFMVAmt>5162144</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>36,313.000 shs Total Bnd Mrkt ETF</StockNm>
        <EOYBookValueAmt>3062074</EOYBookValueAmt>
        <EOYFMVAmt>2670821</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>29,781.000 shs Inter-Term Treasury</StockNm>
        <EOYBookValueAmt>1758270</EOYBookValueAmt>
        <EOYFMVAmt>1766609</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>5,291.000 shs Intl Small-Cap Value ETF</StockNm>
        <EOYBookValueAmt>325922</EOYBookValueAmt>
        <EOYFMVAmt>330635</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>7,095.000 shs USA Quality Factor ETF</StockNm>
        <EOYBookValueAmt>1035507</EOYBookValueAmt>
        <EOYFMVAmt>1043958</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>11,368.000 shs USA Value Factor ETF</StockNm>
        <EOYBookValueAmt>1125772</EOYBookValueAmt>
        <EOYFMVAmt>1149987</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>4,550.000 shs USA Momentum Factor ETF</StockNm>
        <EOYBookValueAmt>702907</EOYBookValueAmt>
        <EOYFMVAmt>713850</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>2,828.000 shs Emerging Mkts ETF</StockNm>
        <EOYBookValueAmt>140862</EOYBookValueAmt>
        <EOYFMVAmt>143040</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>19,939.000 shs Ultra Short-Term Bd ETF</StockNm>
        <EOYBookValueAmt>999542</EOYBookValueAmt>
        <EOYFMVAmt>1004128</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>23,996.000 shs Intl Developed Mkts ETF</StockNm>
        <EOYBookValueAmt>1491317</EOYBookValueAmt>
        <EOYFMVAmt>1527585</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>37,959.000 shs Intl Value Factor ETF</StockNm>
        <EOYBookValueAmt>1003605</EOYBookValueAmt>
        <EOYFMVAmt>1006293</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsOtherSchedule2 documentId="InvestmentsOtherSchedule2" softwareId="23017517" softwareVersionNum="2023v5.1">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #6113382</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>691000</BookValueAmt>
        <EOYFMVAmt>720413</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #6531775</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>675000</BookValueAmt>
        <EOYFMVAmt>557314</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #5121520</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>500000</BookValueAmt>
        <EOYFMVAmt>546258</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #5121519</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>389922</BookValueAmt>
        <EOYFMVAmt>310451</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <LegalFeesSchedule documentId="LegalFeesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <LegalFeesGrp>
        <CategoryTxt>Belin McCormick PC</CategoryTxt>
        <LegalFeesAmt>26798</LegalFeesAmt>
        <NetInvestmentIncomeAmt>26798</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Computer Forensic Services LLC</CategoryTxt>
        <LegalFeesAmt>1764</LegalFeesAmt>
        <NetInvestmentIncomeAmt>1764</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Eckley Law PLLC</CategoryTxt>
        <LegalFeesAmt>6934</LegalFeesAmt>
        <NetInvestmentIncomeAmt>6934</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Heley Duncan &amp; Melander PLLP</CategoryTxt>
        <LegalFeesAmt>100697</LegalFeesAmt>
        <NetInvestmentIncomeAmt>100697</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Larson King</CategoryTxt>
        <LegalFeesAmt>108784</LegalFeesAmt>
        <NetInvestmentIncomeAmt>108784</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Reid &amp; Riege PC</CategoryTxt>
        <LegalFeesAmt>1283</LegalFeesAmt>
        <NetInvestmentIncomeAmt>1283</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>SLCG Economic Consulting LLC</CategoryTxt>
        <LegalFeesAmt>15000</LegalFeesAmt>
        <NetInvestmentIncomeAmt>15000</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherExpensesSchedule documentId="OtherExpensesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <OtherExpensesScheduleGrp>
        <Desc>Bank Charges</Desc>
        <RevenueAndExpensesPerBooksAmt>686</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>686</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Business Meals</Desc>
        <RevenueAndExpensesPerBooksAmt>7101</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>7101</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Contract Services</Desc>
        <RevenueAndExpensesPerBooksAmt>195519</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>195519</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Dues and Subscriptions</Desc>
        <RevenueAndExpensesPerBooksAmt>3758</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>3758</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Events</Desc>
        <RevenueAndExpensesPerBooksAmt>26000</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>26000</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Insurance</Desc>
        <RevenueAndExpensesPerBooksAmt>7730</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>7730</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>KTRN Meeting</Desc>
        <RevenueAndExpensesPerBooksAmt>125037</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>125037</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Media</Desc>
        <RevenueAndExpensesPerBooksAmt>773</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>773</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MN Unemployement Taxes</Desc>
        <RevenueAndExpensesPerBooksAmt>21509</RevenueAndExpensesPerBooksAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Office Expense</Desc>
        <RevenueAndExpensesPerBooksAmt>954</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>954</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Postage &amp; Delivery</Desc>
        <RevenueAndExpensesPerBooksAmt>183</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>183</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="OtherIncomeSchedule2" softwareId="23017517" softwareVersionNum="2023v5.1">
      <OtherIncomeDetail>
        <Desc>Returned Grants</Desc>
        <RevenueAndExpensesPerBooksAmt>123878</RevenueAndExpensesPerBooksAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherIncreasesSchedule documentId="OtherIncreasesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <OtherIncreasesDetail>
        <Desc>Decrease In Grants Payable</Desc>
        <Amt>8038</Amt>
      </OtherIncreasesDetail>
    </OtherIncreasesSchedule>
    <OtherProfessionalFeesSchedule documentId="OtherProfessionalFeesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Flagship Insurance Services</CategoryTxt>
        <Amt>1260</Amt>
        <NetInvestmentIncomeAmt>1260</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Foster Group Inc</CategoryTxt>
        <Amt>122297</Amt>
        <NetInvestmentIncomeAmt>122297</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Other Professional Fees</CategoryTxt>
        <Amt>5600</Amt>
        <NetInvestmentIncomeAmt>5600</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="TaxesSchedule" softwareId="23017517" softwareVersionNum="2023v5.1">
      <TaxesDetail>
        <CategoryTxt>Federal Excise Taxes</CategoryTxt>
        <Amt>25000</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>Foreign Income Taxes</CategoryTxt>
        <Amt>7179</Amt>
        <NetInvestmentIncomeAmt>7179</NetInvestmentIncomeAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>